0
Skip to Content
Nordic Migraine Symposium 2026
Home
Agenda
Venue & Accommodation
NMS 2025
NMS 2024
NMS 2023
NMS 2022
NMS 2021
NMS 2020
NMS 2019
Contact
REGISTER NOW
Nordic Migraine Symposium 2026
Home
Agenda
Venue & Accommodation
NMS 2025
NMS 2024
NMS 2023
NMS 2022
NMS 2021
NMS 2020
NMS 2019
Contact
REGISTER NOW
Home
Agenda
Venue & Accommodation
Folder: Previous years
Back
NMS 2025
NMS 2024
NMS 2023
NMS 2022
NMS 2021
NMS 2020
NMS 2019
Contact
REGISTER NOW

Menstrual migraine – diagnosis & management

Session 3: Hormones and migraine

Anna Sundholm

MD PhD, Head of ME Neurology, Karolinska University Hospital, Sweden

Download presentation

Previous

Pregnancy & lactation in migraine

Next

Impact of sex hormones in migraine

You Might Also Like

Related Embedded Video Item Thumbnail Challenges in navigating the treatment landscape
Related Embedded Video Item Thumbnail Does increased exercise decrease migraine?
Related Embedded Video Item Thumbnail Anti-CGRPs, should I stay or should I go?
Related Embedded Video Item Thumbnail Neck pain and dizziness, and their relation to migraine
Related Embedded Video Item Thumbnail Nerve blockade in headaches – the scientific rationale

Privacy policy

Teva Privacy Notice |Teva Pharmaceuticals

Legal Notes | Teva Pharmaceuticals

Accessibility Statement

Teva code of conduct


Norway, Finland, Denmark: AJO-DK-NP-00128